Ethos Financial Group »

Cytomx Therapeutics shares owned by Ethos Financial Group

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Ethos Financial Group from 13F filings

Historical chart of Ethos Financial Group investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Ethos Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Ethos Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $76k 24k 3.19

More positions owned by Ethos Financial Group

Schwab U.S. Broad Market Etf Etf (SCHB)
Vanguard S&P 500 Etf Etf (VOO)
Relative Sentiment Tactical Allocation Etf Etf (MOOD)
Abrdn Physical Gold Shares Etf Etf (SGOL)
Alpha Architect 13 Month Box Etf Etf (BOXX)
Schwab Us Large Cap Etf Etf (SCHX)
Vanguard Total World Stock Etf Etf (VT)
Schwab Us Large Cap Growth Etf Etf (SCHG)
Vaneck Morningstar Wide Moat Etf Etf (MOAT)
Spdr S&P 500 Etf Etf (SPY)
Invsc S P 500 Momentum Etf Etf (SPMO)
Schwab Us Large Cap Value Etf Etf (SCHV)
Ishares Tips Bond Etf Etf (TIP)
Ishares Russell 1000 Growth Etf Etf (IWF)
Select Sector Spdr Tr Etf (XLU)

View all positions for Ethos Financial Group

Top funds holding Cytomx Therapeutics

VR Adviser
FMR
Tang Capital Management
Perceptive Advisors
Vanguard Group
OrbiMed Advisors
Commodore Capital
Balyasny Asset Management
Baker Bros. Advisors
Point72 Asset Management
ADAR1 Capital Management
Kynam Capital Management
Rtw Investments
Ikarian Capital
Vivo Capital

View all funds holding Cytomx Therapeutics